2017 Aug 03
Second-generation BTK inhibitors in CLL
Richard R. Furman, M.D., discusses second-generation BTK inhibitors, such as acalabrutinib and BGB-3111 in chronic lymphocytic leukemia (CLL). Read more
2017 Aug 02
Skip the Bone Marrow Biopsy in Follicular Lymphoma?
Clinical trials in patients with follicular lymphoma (FL) mandate that patients undergo bone marrow biopsies (BMBs) at baseline and at subsequent points following treatment in order to monitor response, but the biopsies are unnecessary in most patients, argues Sarah Rutherford, M.D., and colleagues. Read more
2017 Aug 02
Does radiotherapy in unresectable pancreatic cancer add value?
John Ng, M.D., reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer. Read more
2017 Aug 02
Collaborative Research Initiative announces inaugural award winners
Four interdisciplinary teams of physicians and scientists from Weill Cornell Medicine have been announced as recipients of the Sandra and Edward Meyer Cancer Center's inaugural Collaborative Research Initiative pilot project grants. Read more
2017 Jul 31
Driving discovery: Two teams uncover new player in prostate cancer formation
Scientists at the Meyer Cancer Center and Englander Institute have identified ERF as a prostate cancer tumor suppressor gene. Read more
2017 Jul 30
It doesn’t take a warrior to beat cancer. It takes a treatment that works.
Your response to treatment is a biological one, not a psychological one, asserts neurosurgeon Rohan Ramakrishna, M.D. Read more
2017 Jul 28
Mantle Cell Lymphoma: Evaluating the Treatment Landscape
Peter Martin, M.D., reviews the standards of care for mantle cell lymphoma. Read more
2017 Jul 21
Imielinski wins award from Doris Duke Charitable Foundation
Marcin Imielinski, M.D., Ph.D., has received $495,000 to investigate a potential class of genetic changes that may be driving cancer. Read more
2017 Jul 21
Dr. Bishoy Faltas wins prestigious grant from the Department of Defense
Bishoy Faltas, M.D., has been awarded a Career Development Award from the Department of Defense to investigate the biology of a family of proteins thought to drive resistance to chemotherapy in the advanced stages of bladder cancer. Read more
2017 Jul 20
McCain may benefit from glioblastoma treatment advances
Howard Fine, M.D., discusses how molecular tumor analysis is changing the landscape for brain cancer treatment. Read more
2017 Jul 11
Chromosome Rearrangements Drive Formation and Growth of Colorectal Cancer
Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Weill Cornell Medicine investigators. Many of the genetic mutations... Read more
2017 Jul 11
Tackling depression and intimacy issues in patients with MPNs
Nurse Sandra Allen-Bard discusses ways in which she counsels and collects information about her patients more intimate symptoms. Read more
2017 Jul 11
‘Fusion genes’ drive formation and growth of colorectal cancer
Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Lukas Dow, Ph.D. Read more
2017 Jul 10
Investigating a loss to discover a win for prostate cancer patients
Michael Augello, Ph.D., has received a grant to investigate the role of CHD1 loss in prostate cancer progression. Read more
2017 Jul 08
‘Nurse of the Year’ opened up her home to a cancer patient
Feature honoring oncology nurse Karen Pekle. Read more
2017 Jul 01
When the Doctor Becomes a Patient
A cancer diagnosis helped Lisa Roth, M.D., look at healing in a whole new way Read more
2017 Jun 30
Convection-enhanced delivery appears safe in pediatric diffuse intrinsic pontine glioma
Mark Souweidane, M.D., reports on his unique drug delivery system to treat the rare pediatric brain tumor DIPG. Read more
2017 Jun 28
Weill Cornell uses HL7 to help integrate structured genomic data into Epic EHR
Moving beyond the PDF, Weill Cornell Medicine enables precision medical records for advanced oncology. Read more
2017 Jun 26
Enzyme key to triggering anti-cancer immune response
An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy’s ability to trigger an immune response against cancer, according to Sandra Demaria and colleagues. Read more
2017 Jun 22
Expert sheds light on lesser-known T-cell lymphoma subtypes
Adult T-cell lymphoma/leukemia (ATLL), a rare subtype of peripheral T-cell lymphoma, presents very differently and can be more prevalent in certain worldwide demographics compared with others, explains Adrienne A. Phillips, M.D. Read more
